CHELSEA THERAPEUTICS INT'L LTD
CHTP
CHTP was delisted on the 23rd of June, 2014.
78 hedge funds and large institutions have $128M invested in CHELSEA THERAPEUTICS INT'L LTD in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 9 closing their positions.
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
61% more capital invested
Capital invested by funds: $79.5M → $128M (+$48.7M)
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
29% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $8.87M
13% more funds holding
Funds holding: 69 → 78 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$5.07M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.16M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.25M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.13M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$5.8M |
| 2 |
VM
VHCP Management
New York
|
-$2.76M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$1.51M |
| 4 |
RA
Royce & Associates
New York
|
-$1.49M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$888K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NES
76
New England Securities
New York
| $1K | – | – | – |
|
|
WEC
77
Winslow Evans & Crocker
Boston,
Massachusetts
| $1K | +$1.01K | +300 | New |
|
78
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $245 | -$304 | -90 | -0.2% |
|
|
HCM
79
Highbridge Capital Management
New York
| – | -$335K | -111,614 | Closed |
|
|
DS
80
DRW Securities
Chicago,
Illinois
| – | -$236K | -80,012 | Closed |
|
|
OAM
81
Oxford Asset Management
Oxford,
United Kingdom
| – | -$192K | -63,694 | Closed |
|
82
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$149K | -48,522 | Closed |
|
83
ProShare Advisors
Bethesda,
Maryland
| – | -$128K | -42,377 | Closed |
|
84
JP Morgan Chase
New York
| – | -$52K | -17,240 | Closed |
|
85
SG Americas Securities
New York
| – | -$36K | -12,015 | Closed |
|
86
Ameriprise
Minneapolis,
Minnesota
| – | -$13K | -4,182 | Closed |
|
|
RFC
87
Russell Frank Company
Seattle,
Washington
| – | -$9K | -2,903 | Closed |
|
CHTP Hedge Fund Activity: Q4 2013 in Review
78 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) for Q4 2013, worth a combined $128M — up 61% from $79.5M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CHTP positions and 9 closed out — a net gain of 9 holders — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $5.07M. The largest seller was Perceptive Advisors, cutting an estimated $5.8M.
- 78 institutional investors held CHELSEA THERAPEUTICS INT'L LTD (CHTP) as of Q4 2013, up from 69 in Q3 2013.
- Funds reported $128M of CHELSEA THERAPEUTICS INT'L LTD stock for Q4 2013, up 61% quarter-over-quarter.
- 18 funds opened new CHELSEA THERAPEUTICS INT'L LTD positions in Q4 2013 and 9 closed out, a net change of +9 holders.
- The largest CHELSEA THERAPEUTICS INT'L LTD buyer in Q4 2013 was Visium Asset Management, an estimated $5.07M added.
- The largest CHELSEA THERAPEUTICS INT'L LTD seller in Q4 2013 was Perceptive Advisors, an estimated $5.8M sold.
Based on aggregated 13F filings for Q4 2013.